We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OHRP Should Investigate Novartis Trials, Group Says
OHRP Should Investigate Novartis Trials, Group Says
March 30, 2011
The Office of Human Research Protection (OHRP) has received a letter from the advocacy group Public Citizen requesting that the agency conduct a compliance oversight evaluation of any U.S. institutions involved in six Phase III studies of indacaterol maleate, Novartis’ investigational chronic obstructive pulmonary disease (COPD) treatment.